Full Press Release Details
CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference.
CRSP
CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference
Key Takeaway: CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference
Price reaction · baseline $43.47 (2023-04-12 close) · hit after-hours · clean, no other CRSP news in the window
day 0 close
+16.3%
day 1
+15.7%
day 3 · peak
+19.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension